ArticleBMC public health2026
Stigma related to male-factor infertility in China: a scale development and validation study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesStigma is a prevalent and serious issue among infertile men, yet no culturally appropriate tools are available to assess their experiences in China. This study aimed to develop and validate the Male Infertility Stigma Scale (MISS) to measure stigma among Chinese men with male-factor infertility.
methodsThis study employed a sequential exploratory mixed-methods design. The scale was developed through literature review, semi-structured interviews with patients (n = 10) and healthcare professionals (n = 5), and two rounds of expert consultation (n = 9). Following pilot testing (n = 20), a cross-sectional survey of 432 infertile men was conducted at the Center of Reproductive Medicine, Third Affiliated Hospital of Guangzhou Medical University between February and May 2019. The sample was randomly divided for exploratory factor analysis (EFA, n = 216) and confirmatory factor analysis (CFA, n = 216). Reliability analyses, including internal consistency and test-retest analysis (n = 18), were performed using IBM SPSS Statistics 21.0 and AMOS Statistics 24.0.
resultsThe final 18-item MISS comprises three dimensions: social marginalization (9 items), self-devaluation (6 items), and psychological insecurity (3 items). EFA indicated that these three dimensions explained 60.14% of the total variance. CFA demonstrated good model fit (χ²/df = 3.230, RMSEA = 0.076, CFI = 0.918, GFI = 0.893). The scale exhibited excellent internal consistency (Cronbach’s α = 0.951), split-half reliability (0.884), and test-retest reliability (ICC = 0.945). Content validity was strong (I-CVI: 0.800–1.000, S-CVI = 0.988), and convergent validity was supported by significant negative correlations with the Self-Esteem Scale (SES) (r=-0.209 to -0.443, all p < 0.01).
conclusionThe MISS demonstrates satisfactory reliability and validity, providing a culturally appropriate tool for assessing stigma among Chinese men with male-factor infertility. This instrument can facilitate early identification of individuals experiencing high stigma levels, guide targeted interventions, and advance research on male infertility stigma reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.